fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

World Health Matters: Denmark: Superbug 'overcoat' helps evade test

Written by | 12 Feb 2015

by Gary Finnegan: A superbug present in hospitals across Europe and the US can become resistant to treatment even without undergoing genetic changes, according to a new study… read more.

New insight into risk of ankylosing spondylitis

Written by | 30 Dec 2014

Scientists at the University of Southampton have discovered variations in an enzyme belonging to the immune system that leaves individuals susceptible to Ankylosing Spondylitis.

Australian study casts doubt on sepsis guidelines

Written by | 19 Dec 2014

World Health Matters – Australia- by Gary Finnegan: New research suggests treatment in Australia and New Zealand for patients with sepsis is the best in the world but… read more.

Team finds drug repurposing signal in e-health records

Written by | 3 Dec 2014

With research and development costs for many drugs reaching well into the billions, pharmaceutical companies want more than ever to determine whether their drugs already at market have… read more.

Teens prescribed anti-anxiety or sleep medications more likely to abuse those drugs illegally

Written by | 1 Dec 2014

Substance abuse assessments needed before drugs are prescribed, researchers say.  Teens prescribed anti-anxiety or sleep medications may be up to 12 times more likely to abuse those drugs… read more.

ESMO 2014 Report: Special symposium on ‘Advances in precision medicine of metastatic colorectal cancer’

Written by | 21 Nov 2014

by Denys Wheatley: There is some irony in the title of this symposium because medicine should always be as precise as it can, and advances are expected that… read more.

ESMO 2014 Report: Reclassifying cancer through genomics

Written by | 19 Nov 2014

Keynote lecture: Professor Sir Mike Stratton (Cambridge/Hinxton, UK) by Denys Wheatley.  On the thesis that the genetic understanding of cancer is fundamental to classifying and hence treating patients… read more.

ESMO 2014 Report: How to integrate genome sequencing data in oncology

Written by | 13 Nov 2014

by Denys Wheatley: Chaired by Atsushi Ohtsu and Jean-Yves Douillard, the first speaker Dr Kato (Japan) addressed the issue of the quest for different mutations in the hope… read more.

ESMO 2014 Report: Precision medicine: Panacea or false dawn?

Written by | 6 Nov 2014

Reports from the European Society for Medical Oncology 2014 Congress in Madrid by Denys Wheatley:  In his talk on Visualising the true spectrum of cancer- will we get… read more.

New advice from AAN on opioid prescribing

Written by | 22 Oct 2014

Studies have shown that 50 percent of patients taking opioids for at least three months are still on opioids five years later. A review of the available studies… read more.

Evolocumab shows added cholesterol-lowering efficacy in familial hypercholesterolaemia patients on statins

Written by | 16 Oct 2014

by Bruce Sylvester: Patients with familial hypercholesterolaemia (FH) who are being treated with statins have achieved additional lowering of LDL cholesterol with adjuvant evolocumab therapy, researchers reported on… read more.

No link between suicidal behaviour and drugs for ADHD

Written by | 25 Sep 2014

by Bruce Sylvester – Researchers report that drug therapy for ADHD does not increase the risk of suicide attempts or suicide. The findings were published on June 18,… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.